Your browser doesn't support javascript.
loading
The Negative Association Between NAFLD Severity and CKD in a Non-Diabetic Gouty Population.
Huang, Yajing; Zhou, Yue; Wang, Yahao; Chi, Jingwei; Lv, Wenshan; Wang, Yangang; Chen, Ying.
Afiliação
  • Huang Y; Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Zhou Y; Endocrinology and Metabolism, Fudan University, Shanghai, China.
  • Wang Y; Endocrinology and Metabolism, Fudan University, Shanghai, China.
  • Chi J; Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Lv W; Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Wang Y; Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Chen Y; Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Horm Metab Res ; 54(5): 325-334, 2022 05.
Article em En | MEDLINE | ID: mdl-35378561
ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share common pathogenic mechanisms and risk factors. We aim to evaluate the association between NAFLD and CKD in a non-diabetic gouty population. The retrospective cross sectional study was performed on 1049 non-diabetic gouty participants, who were hospitalized between 2014 and 2020, across 4 districts in Shandong, China. Demographic and clinical characteristics of the study population were collected. The odds ratios (OR) and corresponding 95% confidence intervals (CI) about the NAFLD severity determined by ultrasonography were obtained by multiple logistic regression analysis. An unexpectedly inverse relationship was found between NAFLD severity and the risk of CKD in people with gout. Multivariate logistic regression analysis demonstrated that a higher degree of NAFLD severity is independently associated with a lower risk of CKD in people with gout, after adjusted for age, sex, smoking, gout duration, and metabolic risk factors including obesity, hypertension, hyperglycemia, hyperuricemia, and dyslipidemia, with OR 0.392 (95% CI 0.248-0.619, p<0.001), 0.379 (95% CI 0.233-0.616, p<0.001) and 0.148 (95% CI 0.043-0.512, p=0.003) in participants with mild, moderate, and severe NAFLD, respectively, compared to those without NAFLD. We also observed a weakened association of serum uric acid (SUA) with metabolic risk factors and NAFLD under circumstances of CKD in people with gout (r=-0.054, p=0.466). In conclusion, the presence and severity of NAFLD were negatively associated with the risk of CKD in the non-diabetic gouty population.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Hepatopatia Gordurosa não Alcoólica / Gota Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Horm Metab Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Hepatopatia Gordurosa não Alcoólica / Gota Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Horm Metab Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China